🔔 The Biocom Converge Summit is just weeks away, and Team Medrio can’t wait to attend! If you’re heading to the conference, we probably have a lot in common–you’re passionate about advancing human health and the crucial role that technology plays in pushing it forward. If that sounds like you, let’s connect at the event and chat about the innovations that inspire you the most, and how the right technology strategy can solve some of the biggest pain points blocking progress! Connect with us before the event here: https://bit.ly/4aUQExP #EDC #CDMS #ePRO #RTSM #eConsent #DataQuality #ClinicalDataManagement #ClinicalTrials
Medrio’s Post
More Relevant Posts
-
At the recent MedTech Europe Forum, there was a focus on the positive impact that medical technology is having on healthcare and patient outcomes. The event showcased several innovative trends in MedTech with the potential to tackle the challenges faced by healthcare systems and patients in Europe. Some of the highlights included: - discussions around maximizing the value of advanced technology - the power of digital technologies in risk and compliance automation - leveraging real-world evidence (RWE) in clinical evidence gathering - how the in vitro diagnostics (IVDs) market is changing in Europe. Connect with us for further discussions.
MedTech Europe Forum
themedtechforum.eu
-
At the recent MedTech Europe Forum, there was a focus on the positive impact that medical technology is having on healthcare and patient outcomes. The event showcased several innovative trends in MedTech with the potential to tackle the challenges faced by healthcare systems and patients in Europe. Some of the highlights included: - discussions around maximizing the value of advanced technology - the power of digital technologies in risk and compliance automation - leveraging real-world evidence (RWE) in clinical evidence gathering - how the in vitro diagnostics (IVDs) market is changing in Europe. Connect with us for further discussions.
MedTech Europe Forum
themedtechforum.eu
-
3rd Year CSE Student at BVCOE | Blockchain Enthusiast with Rust experience | C++ for DSA | Python ML | Skilled in Data Science, Predictive Analysis, MySQL, & Power BI | HTML & CSS
🌟 Proud to share my participation in 𝐌𝐢𝐧𝐝𝐌𝐚𝐞𝐥𝐬𝐭𝐫𝐨𝐦 organized by BVPINC on April 30, 2024! 🌟 With my teammates NAVYA SHARMA and Suhani Prasad, we tackled the challenge of improving 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐯𝐞 𝐑&𝐃 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞. The healthcare industry faces significant obstacles in driving innovation, accelerating drug discovery, and enhancing patient outcomes due to fragmented collaboration, limited access to resources, and siloed R&D approaches. Traditional models often lack transparency and inhibit knowledge sharing, resulting in inefficiencies, high costs, and slow progress. To address these challenges, we proposed 𝐌𝐞𝐝𝐢𝐋𝐚𝐛, an innovative open innovation platform and collaborative R&D ecosystem for stakeholders in the healthcare industry. MediLab aims to facilitate collaboration, knowledge sharing, and joint research projects among pharmaceutical companies, healthcare providers, research institutions, and technology providers. Also, Our platform includes an open-access data library, providing a wealth of research data and resources freely available to all stakeholders. By fostering collaboration, sharing resources, and leveraging data-driven insights, MediLab seeks to accelerate the pace of innovation, drive medical breakthroughs, and improve patient outcomes. Participating in this ideathon was truly an enriching experience. It provided us with the opportunity to brainstorm, innovate, and develop solutions for real-world challenges in healthcare. Working with Navya and Suhani was incredibly rewarding, as we combined our diverse skills and perspectives to create a comprehensive solution. The process of ideation, presentation, and receiving feedback was both challenging and enlightening, pushing us to think critically and creatively. This journey has been an incredible experience of discovery and innovation, and I'm excited about the future possibilities our idea can inspire in the healthcare industry! ✨ #MindMaelstrom #Ideathon #HealthcareInnovation #Collaboration #R&D #BVPINC #Teamwork #Innovation #Healthcare
-
-
Helping preserve high brand reputation and make decisions aligned to values at Deloitte Switzerland - Lecturer at SUPSI Lugano
At the recent MedTech Europe Forum, there was a focus on the positive impact that medical technology is having on healthcare and patient outcomes. The event showcased several innovative trends in MedTech with the potential to tackle the challenges faced by healthcare systems and patients in Europe. Some of the highlights included: - discussions around maximizing the value of advanced technology - the power of digital technologies in risk and compliance automation - leveraging real-world evidence (RWE) in clinical evidence gathering - how the in vitro diagnostics (IVDs) market is changing in Europe. Connect with us for further discussions.
MedTech Europe Forum
themedtechforum.eu
-
The Scottish Life Science Summit served as a platform for biotech, medtech, and healthtech companies to exchange insights and discuss the industry's future in Northeast Scotland. Notable participants included EpitogenX, Microplate Dx Limited, TauRx, NovaBiotics Ltd, and Elasmogen Ltd. The UK is a global force in life sciences. Remarkably, it hosts 14% of global clinical trials. Emphasising the 4 P's— prioritising patients, places, partnerships, and people— is key to sector growth. Life science aims to enhance longevity, happiness, and well-being. What role do you play in shaping the future of life sciences? #lifescience #clinicalresearch #innovation
-
-
Experienced Leader Seeking General Management, Strategy and Advisory/BOD Opportunities | Proven Expertise in Driving Growth & Innovation. Interested in driving 2.0 for Contract Research.
Check out the latest updates from our partner Deciphex as they are desinging the future of #digitalpathology.
🚀 Exciting Announcement! 🚀 Join us LIVE on February 26th for the grand unveiling of Patholytix 4.0 - the future of drug safety assessment is here! Our Chief Scientific Officer, Pierre Moulin, alongside CEO, Donal O'Shea, and VP of Business Development, Research Pathology, Colin Doolan, will dive deep into the features of Patholytix 4.0. Discover how we're revolutionising the development of life-changing drugs and compounds, making your studies faster, more accurate, and incredibly efficient. What's on the Agenda? 📊 A Complete System of Record: Patholytix 4.0 emerges as the sole complete System of Record for non-clinical pathology. With automatic report generation, simplify inputs to regulatory submissions and support both regulated and unregulated use cases across drug development. 🧠 AI-Powered Decision Assistance: With our new AI tool, Foresight, achieve streamlined lesion detection in drug safety assessment primary review. Foresight unlocks early failure of non-performant compounds. 🌍 Enhanced Collaboration: Our new web workflow ensures you can review and collaborate from anywhere, on any device, without compromising on quality, security, or regulatory compliance. Anytime, anywhere, peer review is now a reality. 📚 Future-Proof Study Archiving: Confidently archive and reconstruct studies in compliance with GLP guidelines, thanks to Patholytix 4.0's adoption of DICOM Open standards, ensuring data integrity for decades. Don't miss this chance to learn how Patholytix 4.0 is set to transform your drug development cycle. Register here: https://lnkd.in/g7A6kRJC #Patholytix4Launch | #DrugSafetyRevolution | #FutureOfPharma
-
Breaking news: We've hit a major milestone at bioaccess®! First Patients Treated with Sparta Biomedical Ormi Device This isn't just a win for us. It's a leap forward for: • Patients awaiting innovative treatments • MedTech companies eyeing LATAM expansion • The entire Latin American healthcare ecosystem Key takeaway: Latin America is ready for cutting-edge clinical research. Are you considering LATAM for your next trial? Let's connect. Your next breakthrough might be closer than you think. #ClinicalTrials #LatAmMedTech #bioaccess
-
-
👋 Hope to see you at Vitalis in May. I will give a talk on AI and share detailed insights into the most interesting early-stage life science projects in the Nordic region and how AI connects life science and technology. These early stage companies, together with the existing ecosystem, will play a significant role in shaping the future of healthcare. A clear trend is that the boundaries between pharmaceuticals, medical technology, and e-health are gradually fading. Two particularly interesting additions to the matrix are AI and advanced materials, which, when combined, create impressive technological leaps. Pin Tuesday May 14, 2024 14:30 in your cal 😊 Scale Up Life Science Invest, magnus klaesson, Ann-Charlotte Beckman, Nasim Bergman Farrokhnia, Gunilla Englund, Karina Tellinger McNeil, Daniel Forslund, Boel Mörck, Mikael Hoffmann, Karin Gårdmark Östh, Björn Arvidsson
AI as catalyst in the fusion between tech and life science
invitepeople.com
-
Check out the latest article co-authored by Celeste A. Elash, MS, VP eCOA Science at YPrime. "Flexible Approaches to eCOA Administration in Clinical Trials: The Site Perspective" is now live on ScienceDirect Contemporary Clinical Trials Communications.
As part of C-Path's eCOA: Getting Better Together Initiative, the eCOA Consortium and PRO Consortium are pleased to announce that “Flexible approaches to eCOA administration in clinical trials: The site perspective” has been published in Contemporary Clinical Trials Communications. This article presents results of a survey of eCOA-experienced trial sites to understand their challenges and gather suggestions for simplification that may result in a more flexible, site-centric approach to ePRO implementation in clinical trials. Access here: https://lnkd.in/gs6Rj9fb #CPath #eCOAC #PROConsortium #eCOA #clinicalsites #globalhealth #drugdevelopment #datasharing #collaboration #clinicaltrials ActiGraph, assisTek - The eSource Company, Clario, Clinical ink, ICON plc, IQVIA, Kayentis, Koneksa, Mapi Research Trust, Medable, Inc, Medidata Solutions, Medrio, ObvioHealth, Parexel, Red Nucleus, RWS Group, Science 37, Signant Health, Suvoda, TransPerfect Life Sciences uMotif, WCG, YPrime
-
-
Executive Regulatory and Quality Consultant & Trainer | MDR | IVDR | Combination Devices | Clinical | | Conformity Assessment Support
Register now and learn more about the usage of RWE!
RWE-Driven MedTech: Achieving Reliability & Relevance with Real-World Data 3Aware will convene #MedTech innovators next month in Boston, for the 2nd event in our ongoing symposia series: RWE-Driven MedTech. Capacity is limited to 45 seats. Reserve your spot today! 🔗 hubs.ly/Q02Qkh1C0 Featured Topics & Speakers: > Real-World Data Collection to Fulfill Global Evidence Needs - Trevor Carden, Teleflex > Using RWE for Entering New Markets - Bethany Knorr Chung, PhD, RAC, RQM+ > Leveraging RWE to Optimize Device Profitability - Amelia Hufford, PhD, 3Aware > EU MDR: State of Affairs in 2024 - Bassil Akra, PhD > EU Clinical Data Requirements: The Value of RWE Join us as we delve deeper into how Real-World Data can be more effectively and efficiently translated into Real-World Evidence -- for evolving regulatory landscapes, portfolio optimization, and more. 🔗View Full Agenda & Register:🔗 hubs.ly/Q02Qkh1C0
-
